FRI-305-Long acting GLP-1/Glucagon co-agonist ameliorates steatosis, inflammation and fibrogenesis in a rodent model of NASH

Autor:	Kirsten Raun, Jenny Norlin, Anne Bugge, Elisabeth D. Galsgaard, Thomas Kruse Hansen, Markus Latta, Jesper Lau, Dorte Holst
Rok vydání:	2019
Předmět:	Agonist medicine.medical_specialty Hepatology business.industry medicine.drug_class Inflammation Rodent model medicine.disease Glucagon Endocrinology Long acting Internal medicine medicine Steatosis medicine.symptom business
Zdroj:	Journal of Hepatology. 70:e529-e530
ISSN:	0168-8278
DOI:	10.1016/s0618-8278(19)31048-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3aa88f2511b9d137441bc990af905482 https://doi.org/10.1016/s0618-8278(19)31048-5 Zobrazit plný text záznamu Full Text from ScienceDirect